Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985;109:399-411.

Priori SG, Napolitano C, Cantù F, Brown AM, Schwartz PJ. Differential response to Na+ channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the Long QT Syndrome. Circ Res 1996;78:1009-15.

Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantù F, Towbin JA et al. Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in hearth rate. Implications for gene specific therapy. Circulation 1995;92:3381-86.

Brugada P, Brugada J. Right bundle-branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391-96.

Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M et al. Clinical and genetic heterogeneity of the right bundle branch block and ST segment elevation syndrome. A prospective evaluation of 52 families. Circulation 2000;102:2509-15.

Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The Elusive Link between LQT3 and Brugada Syndromes: the role of Flecainide challenge. Circulation 2000;102:945-47.

Coumel P, Fidelle J, Lucet V et al. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 1978;40(suppl):28-37.

Leenhardt A, Lucet V, Denjoy I et al. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995;91:1512-19.

Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al. Mutations in the cardiac Ryanodine Receptor gene (hRyR2) underlie Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 2000;102:r49-r53.